Compounds and methods of targeting interleukin-34

The present disclosure relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and/or compositions thereof to treat immune-mediated diseases, such as neurodegenerative diseases (e.g., Alzheimer's disease or Tauopathies). 本公开涉及IL-34抗体、包含其的组合物、以及使用所述抗体和/...

Full description

Saved in:
Bibliographic Details
Main Authors SCOLA, ANDREW, DAVID, MINTHONG MILIND, WEST ERIC ANTHONY, LOO ALEXANDER, SIMS, JOHN, R., II, WALSH, RICHARD, E, CHEAD MICHAEL, FLEISCHER AMY S, RANNAN MANISH BABU, RAINES, SCOTT, E, OBUNGU VICTOR H, YE, MING
Format Patent
LanguageChinese
English
Published 09.08.2024
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and/or compositions thereof to treat immune-mediated diseases, such as neurodegenerative diseases (e.g., Alzheimer's disease or Tauopathies). 本公开涉及IL-34抗体、包含其的组合物、以及使用所述抗体和/或其组合物治疗免疫介导的疾病例如神经退行性疾病(例如阿尔茨海默病或Tau蛋白病)的方法。
Bibliography:Application Number: CN20228086891